Toripalimab (Anti-PDCD1 / PD-1 / CD279)
Toripalimab (Anti-PDCD1 / PD-1 / CD279) is a recombinant, humanized monoclonal antibody targeting PD-1. It has exhibited primary anti-tumor effects in tumors such as melanoma, lung cancer, digestive tract tumors, hepatobiliary and pancreatic tumors, neuroendocrine neoplasms, nasopharyngeal carcinoma and urothelial carcinoma. 147.3 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A3082 |
Sku # | A3082-1mg |
Pricing | 1mg, $170.00 |